Plexus Corp. (NASDAQ:PLXS) Receives $238.33 Average PT from Analysts

Plexus Corp. (NASDAQ:PLXS) has received a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $238.3333.

A number of brokerages have weighed in on PLXS. Zacks Research lowered shares of Plexus from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 20th. Needham & Company LLC boosted their target price on shares of Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday, June 11th. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Raymond James Financial restated an “outperform” rating and set a $275.00 target price on shares of Plexus in a report on Thursday, April 30th.

Insider Activity at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 3,000 shares of the stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $268.45, for a total transaction of $805,350.00. Following the transaction, the chief executive officer owned 74,888 shares in the company, valued at $20,103,683.60. This trade represents a 3.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $264.75, for a total value of $865,732.50. Following the transaction, the executive vice president owned 16,266 shares in the company, valued at $4,306,423.50. The trade was a 16.74% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 21,981 shares of company stock worth $5,855,318. Insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

Several institutional investors and hedge funds have recently modified their holdings of the business. Glenmede Trust Co. NA grew its stake in shares of Plexus by 14.3% in the first quarter. Glenmede Trust Co. NA now owns 2,329 shares of the technology company’s stock valued at $472,000 after acquiring an additional 292 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Plexus by 0.3% in the first quarter. Bank of America Corp DE now owns 175,832 shares of the technology company’s stock valued at $35,613,000 after acquiring an additional 573 shares in the last quarter. Intrinsic Edge Capital Management LLC acquired a new position in shares of Plexus in the first quarter valued at about $4,253,000. Smith Group Asset Management LLC grew its stake in shares of Plexus by 9.3% in the first quarter. Smith Group Asset Management LLC now owns 4,830 shares of the technology company’s stock valued at $978,000 after acquiring an additional 409 shares in the last quarter. Finally, Amundi grew its stake in shares of Plexus by 143.0% in the first quarter. Amundi now owns 31,294 shares of the technology company’s stock valued at $6,338,000 after acquiring an additional 18,418 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Price Performance

Plexus stock opened at $299.97 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.54 and a quick ratio of 0.74. Plexus has a fifty-two week low of $115.35 and a fifty-two week high of $304.90. The company’s 50 day simple moving average is $262.19 and its 200 day simple moving average is $209.83. The firm has a market capitalization of $8.03 billion, a price-to-earnings ratio of 43.86 and a beta of 0.89.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the firm posted $1.66 earnings per share. The business’s revenue was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, sell-side analysts anticipate that Plexus will post 5.98 EPS for the current year.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.